00:00 What is the role of AVI in hematology?
00:04 The role of AVI in hematology is a real vocation.
00:08 I always define the progress made by AVI in hematology as absolutely identical.
00:14 The first scientific data, we are moving with the rapidity of science,
00:18 date back to the first day when AVI was founded
00:22 and they are the ones that finally brought to the patients the possibility of inhibition of BCL2,
00:30 an absolutely fundamental molecule in the regulation of the natural death processes regulated by blood tumors.
00:37 It is therefore more than 10 years that we are investing in research in hematology
00:42 and today we reap the fruits of what is a product that represents a pipeline in itself
00:50 and that of chronic lymphatic leukemia is the first experiment made with a drug that represents the first and only in its class.
00:59 Research has made incredible progress and probably the best expectation is to restore to patients quality of life and time of life.
01:09 We all know how a diagnosis represents for a patient a new life partner who never abandons him.
01:16 What we can do with the new target therapies is to interrupt the therapy.
01:22 As you will hear, the current possibility is to conduct an important and effective therapy for a year, two years and then allow us to interrupt it,
01:32 thus moving away from the patient both what we call the burden of the disease,
01:37 therefore the weight of the disease, but also having to take drugs that have a normal effect of toxicity.
01:44 Therefore, the supply of an effective drug, but which is possible to interrupt for a year or two, greatly reduces the risk of toxicity,
01:53 thus bringing an advantage to both the patient's quality of life, which is the first thing for us,
01:58 and to the management of the doctor, who thus manages more patients at the same time.
02:03 [BLANK_AUDIO]